Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03402802 · ClinicalTrials.gov registry record

Steroid Eyedrop Adherence After Trabeculectomy

A clinical trial of Glaucoma and Adherence, Patient, sponsored by Johns Hopkins University.

Completed
Registry status
92
Enrollment target
1
Study location

NCT03402802: Completed study of Glaucoma and Adherence, Patient, sponsored by Johns Hopkins University.

NCT03402802 is a study of Glaucoma and Adherence, Patient that has completed, run by Johns Hopkins University. The registered enrollment target is 92 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03402802, a study of Glaucoma and Adherence, Patient, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
92 participants
Enrollment target
1
Study location

Study Summary

The study will monitor how often persons use eye drops that are prescribed after glaucoma surgery and will compare the adherence with drop use to the success rate of the surgery.

Primary Outcome

frequency of taking eye drops

Conditions Studied

Glaucoma Adherence, Patient

Interventions

  • DRUG monitoring of adherence with medication

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2019-09-01
Est. Completion 2021-08-25
Johns Hopkins University

1,448 total trials

What the finished NCT03402802 record still lists

NCT03402802 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which monitoring of adherence with medication is the first listed.

NCT03402802 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03402802 about?

NCT03402802 is a clinical study titled "Steroid Eyedrop Adherence After Trabeculectomy". The study will monitor how often persons use eye drops that are prescribed after glaucoma surgery and will compare the adherence with drop use to the success rate of the surgery.

What is the current status of trial NCT03402802?

This trial is currently completed. The enrollment target is 92 participants. The study started on 2019-09-01. Estimated completion is 2021-08-25.

What conditions does trial NCT03402802 study?

This clinical trial studies the following conditions: Glaucoma, Adherence, Patient.

What interventions are being tested in trial NCT03402802?

The interventions under investigation include: monitoring of adherence with medication (DRUG).

Who is sponsoring clinical trial NCT03402802?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03402802 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03402802's enrollment target sits among peer trials

92 47th of 92 higher than 46 of 92 other Glaucoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03402802, the US trial registry maintained by the National Library of Medicine. NCT03402802 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.